Products in Development
The research and development team at MBS strives to develop broadly applicable, quality antibodies that are rich in technical collateral. Through careful project design and complete control over development and production, the best and most price flexible products possible are added to our growing catalog.
In Development Notes and Technical Updates:
Dengue Fever: Subclones are in the final stage of assay validation for the recognition of native Dengue NS1
Campylobactor jejuni: Immunizations are complete with fusion scheduled for the end of November
Chikungunya virus: Immunizations are complete with first test bleed scheduled for mid November
GST: Multiple positive clones being assessed and characterized using MultiPure technology
Tetanus Toxoid/Measles/Hib – Project planning phase
If you have a suggestion for a new antibody product please contact us.